ProfessionalsBrianna van Kan
Tel: +1-212-373-2247
Fax: +1-347-438-3157
bvankan@paulweiss.com
1285 Avenue of the Americas
New York,
NY
10019-6064
Fax: +1-347-438-3157
Brianna van Kan focuses her practice on matters involving IP and technology assets. She has advised on the intellectual property aspects of myriad complex corporate transactions, including mergers and acquisitions, carve-outs, spinoffs, joint ventures, financings and restructurings. She has experience working with clients across a variety of industries including technology, financial services, pharmaceuticals and retail, among others, in negotiations of patent, software, data and technology licenses, collaboration, branding, endorsement and services agreements, and other similar commercial agreements. In addition to such transactional work, she supports internal client functions by advising on policies, providing guidance on strategic contract compliance at critical junctures, and analyzing legal risks and developing creative solutions in relation to novel technologies.
Brianna also brings to her practice keen insight into the business perspectives and realities of her clients from her experience serving as product counsel for a consumer technology company’s machine-learning and AI functions, in which role she participated in cross-functional development of strategic global responses to proposed AI legislation, generated novel contract templates for certain AI use cases and proposed risk-based approaches for new product launches.
EXPERIENCE
Brianna’s recent representations include:
- Altor in its acquisition of CCM Hockey
- AbbVie in its up to $212.5 million acquisition of Landos Biopharma
- Casey’s General Stores in its $1.145 billion acquisition of Fikes Wholesale, owner of CEFCO Convenience Stores
- Diamond Sports Group, the nation’s largest owner of regional sports networks, in connection with its chapter 11 cases filed in the Bankruptcy Court for the Southern District of Texas
- IBM in its:
- strategic partnership with Palo Alto Networks
- pending $6.4 billion acquisition of HashiCorp
- Rodina Capital in:
- in the sale of its portfolio company Wastech Corp. to Routeware
- its acquisition of Rubicon Technologies’ fleet technology business
- Strategic Value Partners in its $1.125 billion acquisition of Revelyst, a segment of Vista Outdoor
- ZT Systems in its $4.9 billion sale to Advanced Micro Devices (AMD)
Prior to Paul, Weiss
- DuPont in numerous matters, including:
- the separation of DowDuPont into three publicly traded companies the $39 billion spin-off of Dow and $19 billion spin-off of Corteva
- the sale of a portion of its crop protection business to FMC Corporation in exchange for substantially all of FMC’s health and nutrition business and a balancing payment of $1.625 billion
- the $45.4 billion reverse Morris trust spin-off and merger of its Nutrition & Biosciences business with International Flavors & Fragrances
- Reinvent Technology Partners in its SPAC merger with Joby Aviation at an enterprise value of $6.6 billion
- Brookfield Asset Management in various transactions, including in its $3.5 billion acquisition of an additional 30% stake in FirstEnergy Transmission and deal with Closed Loop Partners to establish and invest in Circular Services, a joint venture in the recycling space
- Dassault Systèmes in its $5.8 billion acquisition of Medidata Solutions
- Gilead Sciences in its $11.9 billion acquisition of Kite Pharma
- Pfizer in its $1 billion sale of Hospira infusion Systems to ICU Medical
- Artist Partner Group, one of the largest U.S. independent music labels, in its sale to Atlantic Records
- Shamrock Capital Advisors in its acquisition of the masters and other rights to Taylor Swift's first six albums
- Jon Bon Jovi in a joint venture to launch a Hamptons-inspired rosé wine in partnership with French winemaker Gérard Bertrand
- A Fortune 10 company in several partnerships involving development and implementation of warehouse automation technology